We are monitoring the impact of COVID-19 on Asia-Pacific Interventional Neurology Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1631
Share on
Share on

Asia Pacific Neurovascular Devices/Interventional Neurology Market Research Report – Segmented By Technology, Product, End-users and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1631
Pages: 132

APAC Interventional Neurology Market Size (2021 to 2026)

The Asia-Pacific Interventional Neurology Market was worth USD 450.04 million in 2021 and is estimated to reach USD 724.13 million by the end of 2026 with a growing potential of 9.98%. The Asia-Pacific Interventional Neurology market is expected to show the highest CAGR over the forecast period. It is due to increasing awareness among the neurologists related to the benefits of interventional neurology devices and decreasing the prices of neurovascular devices in the Asia-Pacific.

Easy access to recent technologies, growing discretionary expenses, and increasing neurovascular devices' adoption amidst the neurosurgeons are expected to propel the market in the Asia Pacific region. High-stress levels in youth and increasing head injuries due to road accidents are further expected to favor market growth.

In 2018, the Indian government had spent around USD 1.14 Billion to increase the awareness of the CNS diseases in public considering the increasing number of neurological disease cases in the country, As per the Indian Brand Equity Foundation. Furthermore, according to the World Health Organization, neurological disorder accounts for 6.3% of the disease burden worldwide. This rising disease prevalence is also estimated to provide a boost to the market growth.

The shortage of skilled and experienced professionals is estimated to hamper market growth to a small extent. Notably, Japan is facing a scarcity of neurosurgeons for the last five years. Strict regulatory policies by the U.S. FDA for interventional neurology devices' approval is a key factor restraining the market.

This market research report on the Asia Pacific Neurovascular Devices/Interventional Neurology Market has been segmented and sub-segmented into the following categories:

  • By Technology: Embolization and Coiling, Balloon Angioplasty, Carotid Stenting, Neurothrombectomy, and Micro Support Devices
  • By Product: Carotid Stent, Microcatheter, Flow Diversion, Microguidewires, Suction Device, Stenting Systems, and Clot Retrieval
  • By End User: Hospitals, Ambulatory Centers and Neurology Clinics
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regional Analysis:

The Asia-Pacific market is expected to grow at the fastest growth rate across all the regions as it has a giant patient pool, a massive number of people suffering from neurovascular disorders that affect the human brain and damage. 

In this region, Japan was accounted for the largest share in 2019 and is expected to dominate the market during the forecast period due to low technology manufacturing costs and key players' availability. 

China and India are expected to grow rapidly from 2020 to 2025. In countries like China and India, the market is driven by factors like quick and speedy healthcare infrastructure developments, huge investments made by the key players in the neurology devices, and growing healthcare expenditures. 

Some of the major players in the Asia-Pacific Interventional Neurology Market are Stryker Corporation, Merit Medical Systems Inc., Medtronic plc, Terumo Corporation, Johnson & Johnson, Microport Scientific Corporation, Penumbra Inc., Abbott Laboratories, W. L. Gore & Associates Inc., and Medikit Co., Ltd.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Technology                 

                                5.1.1 Introduction           

                                5.1.2 Embolization and Coiling   

                                5.1.3 Angioplasty             

                                5.1.4 Carotid Stenting    

                                5.1.5 Neurothrombectomy         

                                5.1.6 Micro support devices       

                                5.1.7 Others      

                                5.1.8  Y-o-Y Growth Analysis, By Technology       

                                5.1.9  Market Attractiveness Analysis, By Technology     

                                5.1.10  Market Share Analysis, By Technology    

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Carotid Stent          

                                5.2.3 Microcatheter       

                                5.2.4 Flow Diversion       

                                5.2.5 Microguidewires  

                                5.2.6 Suction Device       

                                5.2.7 stenting systems  

                                5.2.8 Clot Retrieval         

                                5.2.9 Others      

                                5.2.10  Y-o-Y Growth Analysis, By Product            

                                5.2.11  Market Attractiveness Analysis, By Product          

                                5.2.12  Market Share Analysis, By Product            

                5.3 End-users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Ambulatory centers            

                                5.3.4 Neurology clinics  

                                5.3.5 Others      

                                5.3.6  Y-o-Y Growth Analysis, By End-users          

                                5.3.7  Market Attractiveness Analysis, By End-users        

                                5.3.8  Market Share Analysis, By End-users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technology

                                                6.1.3.3 By Product

                                                6.1.3.4 By End-users

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technology

                                                6.1.4.3 By Product

                                                6.1.4.4 By End-users

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Product

                                                6.1.5.4 By End-users

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Stryker Corporation                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Medtronic plc                            

                8.3 Johnson & Johnson                 

                8.4 Terumo Corporation                               

                8.5 Penumbra Inc.                          

                8.6 Abbott Laboratories                               

                8.7 Merit Medical Systems Inc.                 

                8.8 W. L. Gore & Associates Inc.                

                8.9 Microport Scientific Corporation                       

                8.10 Medikit Co., Ltd                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Interventional Neurology Market, By Technology, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Embolization and Coiling Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Angioplasty Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Carotid Stenting Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Neurothrombectomy Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Micro support devices Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Interventional Neurology Market, By Product, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Carotid Stent Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Microcatheter Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Flow Diversion Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Microguidewires Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Suction Device Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific stenting systems Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia-Pacific Clot Retrieval Market, By Region, From 2021 to 2026 (USD Million)
  15. Asia-Pacific Interventional Neurology Market, By End users, From 2021 to 2026 (USD Million)
  16. Asia-Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  17. Asia-Pacific Ambulatory centers Market, By Region, From 2021 to 2026 (USD Million)
  18. Asia-Pacific Neurology clinics Market, By Region, From 2021 to 2026 (USD Million)
  19. Japan Interventional Neurology Market, By Technology, From 2021 to 2026 (USD Million)
  20. Japan Interventional Neurology Market, By Product, From 2021 to 2026 (USD Million)
  21. Japan Interventional Neurology Market, By End users, From 2021 to 2026 (USD Million)
  22. China Interventional Neurology Market, By Technology, From 2021 to 2026 (USD Million)
  23. China Interventional Neurology Market, By Product, From 2021 to 2026 (USD Million)
  24. China Interventional Neurology Market, By End users, From 2021 to 2026 (USD Million)
  25. India Interventional Neurology Market, By Technology, From 2021 to 2026 (USD Million)
  26. India Interventional Neurology Market, By Product, From 2021 to 2026 (USD Million)
  27. India Interventional Neurology Market, By End users, From 2021 to 2026 (USD Million)
  28. Australia Interventional Neurology Market, By Technology, From 2021 to 2026 (USD Million)
  29. Australia Interventional Neurology Market, By Product, From 2021 to 2026 (USD Million)
  30. Australia Interventional Neurology Market, By End users, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample